Households and businesses made up nearly half of the spending, meaning consumers are unable to spend in other sectors and businesses are crunched for resources.
Of that total, $451 million was spent on men who were diagnosed with prostate cancer graded with a Gleason score of 6, considered unworthy of aggressive treatment.